Sobhani I, Bado A, Vissuzaine C, Buyse M, Kermorgant S, Laigneau J P, Attoub S, Lehy T, Henin D, Mignon M, Lewin M J
Service de Gastroentérologie et Nutrition, Hôpital Bichat-Claude Bernard, Paris, France.
Gut. 2000 Aug;47(2):178-83. doi: 10.1136/gut.47.2.178.
The circulating peptide leptin produced by fat cells acts on central receptors to control food intake and body weight homeostasis. Contrary to initial reports, leptin expression has also been detected in the human placenta, muscles, and recently, in rat gastric chief cells. Here we investigate the possible presence of leptin and leptin receptor in the human stomach.
Leptin and leptin receptor expression were assessed by immunohistochemistry, reverse transcriptase-polymerase chain reaction (RT-PCR), and western blot analysis on biopsy samples from 24 normal individuals. Fourteen (10 healthy volunteers and four patients with non-ulcer dyspepsia and normal gastric mucosa histology) were analysed for gastric secretions. Plasma and fundic mucosa leptin content was determined by radioimmunoassay.
In fundic biopsies from normal individuals, immunoreactive leptin cells were found in the lower half of the fundic glands. mRNA encoding ob protein was detected in the corpus of the human stomach. The amount of fundic leptin was 10.4 (3.7) ng leptin/g mucosa, as determined by radioimmunoassay. Intravenous infusions of pentagastrin or secretin caused an increase in circulating leptin levels and leptin release into the gastric juice. The leptin receptor was present in the basolateral membranes of fundic and antral gastric cells. mRNA encoding Ob-RL was detected in both the corpus and antrum, consistent with a protein of approximately 120 kDa detected by immunoblotting.
These data provide the first evidence of the presence of leptin and leptin receptor proteins in the human stomach and suggest that gastric epithelial cells may be direct targets for leptin. Therefore, we conclude that leptin may have a physiological role in the human stomach, although much work is required to establish this.
脂肪细胞产生的循环肽瘦素作用于中枢受体,以控制食物摄入和体重稳态。与最初的报道相反,瘦素表达也已在人胎盘、肌肉中被检测到,最近在大鼠胃主细胞中也有发现。在此,我们研究人胃中瘦素和瘦素受体的可能存在情况。
通过免疫组织化学、逆转录聚合酶链反应(RT-PCR)以及对24名正常个体活检样本的蛋白质印迹分析来评估瘦素和瘦素受体的表达。对14名个体(10名健康志愿者和4名非溃疡性消化不良且胃黏膜组织学正常的患者)的胃分泌物进行了分析。通过放射免疫测定法测定血浆和胃底黏膜中的瘦素含量。
在正常个体的胃底活检组织中,在胃底腺下半部发现了免疫反应性瘦素细胞。在人胃体中检测到了编码ob蛋白的mRNA。通过放射免疫测定法确定,胃底瘦素含量为10.4(3.7)ng瘦素/克黏膜。静脉输注五肽胃泌素或促胰液素会导致循环瘦素水平升高以及瘦素释放到胃液中。瘦素受体存在于胃底和胃窦胃细胞的基底外侧膜中。在胃体和胃窦中均检测到了编码Ob-RL的mRNA,这与免疫印迹法检测到的约120 kDa的蛋白质一致。
这些数据首次证明了人胃中存在瘦素和瘦素受体蛋白,并表明胃上皮细胞可能是瘦素的直接靶标。因此,我们得出结论,瘦素可能在人胃中具有生理作用,尽管还需要大量工作来证实这一点。